CEP-3009

N/A

Report date: 2025/01/26 18:02:51

NME

Base Information

Drug NameCEP-3009

Drug Alias NameCEP-3009

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionApoptosis stimulants

TargetsUpdating

Therapy Area/IndicationsLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelprogen

China Registration ClassN/A

Active CompaniesCelprogen

Inactive CompaniesN/A

Active IndicationsLiver Neoplasms

Inactive IndicationsN/A

ATC CodeN/A